SRD Young Investigator Award 2017 : Risk of chromosomal aberration in spermatozoa during intracytoplasmic sperm injection

  • WATANABE Hiroyuki
    Department of Biological Sciences, Asahikawa Medical University, Hokkaido 078-8510, Japan

書誌事項

タイトル別名
  • Risk of chromosomal aberration in spermatozoa during intracytoplasmic sperm injection

この論文をさがす

抄録

<p> Intracytoplasmic sperm injection (ICSI) has become critical for the treatment of severe male infertility. The principal feature of ICSI is the direct injection of spermatozoon into an oocyte, which facilitates the production of fertilized embryos regardless of semen characteristics, such as sperm concentration and motility. However, the chromosomal integrity of ICSI zygotes is degraded compared to that of zygotes obtained via in vitro fertilization. This chromosomal damage may occur due to the injection of non-capacitated, acrosome-intact spermatozoa, which never enter the oocytes under natural fertilization. Furthermore, it is possible that the in vitro incubation and pre-treatment of spermatozoa during ICSI results in DNA damage. Chromosomal aberrations in embryos induce early pregnancy losses. However, these issues may be overcome by embryo production using gametes with guaranteed chromosomal integrity. Because conventional chromosome analysis requires fixing cells to obtain the chromosome spreads, embryos cannot be produced using the nucleus that has been analyzed. On the other hand, genome cloning using androgenic or gynogenic embryos provides an additional nucleus for chromosome analysis following embryo production. Thus, this review aims to highlight the hazardous nature of chromosomal aberrations in sperm during ICSI and to introduce a method for the prezygotic examination for chromosomal aberrations.</p>

収録刊行物

参考文献 (69)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ